Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Prestige Consumer Healthcare stock

PBH
US74112D1019
A0DN17

Price

72.10
Today +/-
+0.70
Today %
+1.09 %
P

Prestige Consumer Healthcare stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Prestige Consumer Healthcare stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Prestige Consumer Healthcare stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Prestige Consumer Healthcare stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Prestige Consumer Healthcare's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Prestige Consumer Healthcare Stock Price History

DatePrestige Consumer Healthcare Price
9/30/202472.10 undefined
9/27/202471.32 undefined
9/26/202471.35 undefined
9/25/202470.78 undefined
9/24/202471.13 undefined
9/23/202472.29 undefined
9/20/202473.03 undefined
9/19/202473.92 undefined
9/18/202473.53 undefined
9/17/202473.55 undefined
9/16/202473.68 undefined
9/13/202474.12 undefined
9/12/202472.91 undefined
9/11/202471.12 undefined
9/10/202472.11 undefined
9/9/202472.63 undefined
9/6/202474.34 undefined
9/5/202475.08 undefined
9/4/202475.50 undefined
9/3/202474.09 undefined

Prestige Consumer Healthcare Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Prestige Consumer Healthcare, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Prestige Consumer Healthcare from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Prestige Consumer Healthcare’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Prestige Consumer Healthcare. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Prestige Consumer Healthcare’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Prestige Consumer Healthcare’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Prestige Consumer Healthcare’s growth potential.

Prestige Consumer Healthcare Revenue, EBIT and net profit per share

DatePrestige Consumer Healthcare RevenuePrestige Consumer Healthcare EBITPrestige Consumer Healthcare Net Income
2029e1.25 B undefined391.88 M undefined280.81 M undefined
2028e1.22 B undefined379.76 M undefined259.29 M undefined
2027e1.2 B undefined367.64 M undefined245.77 M undefined
2026e1.17 B undefined355.4 M undefined237.55 M undefined
2025e1.14 B undefined345.9 M undefined221.35 M undefined
20241.13 B undefined342.43 M undefined209.34 M undefined
20231.13 B undefined352.9 M undefined-82.31 M undefined
20221.09 B undefined329.92 M undefined205.38 M undefined
2021943.4 M undefined297.4 M undefined164.7 M undefined
2020963 M undefined300.4 M undefined142.3 M undefined
2019975.8 M undefined300.9 M undefined-35.8 M undefined
20181.04 B undefined321.8 M undefined339.6 M undefined
2017882.1 M undefined273.4 M undefined69.4 M undefined
2016806.2 M undefined262.7 M undefined99.9 M undefined
2015714.6 M undefined209.3 M undefined78.3 M undefined
2014597.4 M undefined188.6 M undefined72.6 M undefined
2013623.6 M undefined191.8 M undefined65.5 M undefined
2012441.1 M undefined102.8 M undefined37.2 M undefined
2011336.5 M undefined76.1 M undefined29.2 M undefined
2010292.6 M undefined78.4 M undefined32.1 M undefined
2009294.3 M undefined77.3 M undefined-186.8 M undefined
2008306.6 M undefined87 M undefined33.9 M undefined
2007296 M undefined88.7 M undefined36.1 M undefined
2006296.7 M undefined93.2 M undefined26.3 M undefined
2005289.1 M undefined90.4 M undefined-15.2 M undefined

Prestige Consumer Healthcare Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.050.070.090.290.30.30.310.290.290.340.440.620.60.710.810.881.040.980.960.941.091.131.131.141.171.21.221.25
-54.3519.72240.002.42-3.38-3.92-0.6815.0731.2541.27-4.1719.6012.899.4318.03-6.34-1.23-2.0815.163.78-0.181.602.542.561.502.13
58.7061.9757.6551.9053.0452.7052.2952.7252.4050.6051.4755.7056.1156.8657.9456.6955.7256.9258.2658.0157.0955.4655.47-----
27444915015715616015515317022734733540646750058055556154762062562400000
9161890938887777876102191188209262273321300300297329352342345355367379391
19.5722.5421.1831.1431.4229.7328.4326.1926.7122.6223.1330.6631.4929.2732.5130.9530.8430.7731.1531.5030.2931.2330.4030.1830.2930.5331.0731.38
0-143-15263633-1863229376572789969339-35142164205-82209221237245259280
---121.43-600.00-273.3338.46-8.33-663.64-117.20-9.3827.5975.6810.778.3326.92-30.30391.30-110.32-505.7115.4925.00-140.00-354.885.747.243.385.718.11
505026.627.550505049.950.150.350.751.452.352.753.153.453.552.151.150.650.8449.8950.1800000
----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Prestige Consumer Healthcare Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Prestige Consumer Healthcare is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                           
3.53.45.38.213.86.135.241.113.31915.728.321.327.241.932.527.594.832.327.1958.4946.47
131335.138.233.542.834.92943.750.972.465.185.594135.3140.1148.1150114.6139.33167.02176.78
0.20.40.81.81.71.41.11.60.79.30.702.41.21.40.80.70.50.1000
5.610.724.833.830.229.725.927.739.851.160.265.67491.3115.6118.5119.9116115120.34162.12138.72
1.31.88.93.94.65.46.512.710.116.715.218.218.535.340.211.54.74.47.96.414.1213.08
23.629.374.985.983.885.4103.6112.1107.6147164.2177.2201.7249334.4303.4300.9365.7269.9293.27391.74375.04
0.60.92.31.71.41.41.41.41.41.39.99.613.715.550.652.651.290.7102.898.5389.5489.33
0000000000000000000000
0000000000000000000000
0.110.240.610.640.660.650.570.550.791.41.371.392.132.322.92.782.512.482.482.72.342.32
055.8294.7297.9310.9308.9114.2111.5154.9173.7167.5190.9290.7360.2615.3620.1578.6575.2578.1578.98527.55527.73
5.22.81615.810.16.813.1126.635.724.923.21.21.37.53.63.132.93.273.015.73
0.120.30.920.950.980.960.70.680.951.611.581.622.442.73.583.463.143.153.163.382.962.94
0.140.3311.041.061.050.80.791.061.761.741.82.642.953.913.763.443.513.433.673.353.32
                                           
0.1119.90.50.50.50.50.50.50.50.80.80.50.50.50.50.50.50.50.50.540.550.56
56.84.9378.3378.6379.2380.4382.8384387.9391.9401.7414.4426.6445.2458.3468.8479.2488.1499.5515.58535.36567.45
-0.01000.030.070.1-0.09-0.06-0.030.010.080.150.230.330.40.740.70.841.011.211.131.34
-0.700.31.10.3-1-1.3000-0.10.7-23.4-23.5-26.4-19.3-25.7-39.3-18-19.03-31.56-34.5
00000000000000000-4.9-1.8000
0.040.130.380.410.450.480.290.330.360.40.480.560.630.750.831.191.161.291.491.711.641.87
4.45.321.718.119.320.515.912.821.626.751.448.346.138.370.261.456.662.44655.7662.7438.98
9.16.611.612.118.113.814.113.332.136.644.834.250.358.46959.970.381.271.982.2484.4974.01
0001.8000.700.50.60.51.92.61022.81.90.15.11.72.6710.652.57
0000000000000000000000
19.623.73.73.63.63.629.60000000001.22.62.752.831.49
33.113.93735.74137.934.355.754.263.996.784.499106.7162123.2127149.9122.2143.42160.72117.05
0.060.150.490.490.460.410.370.290.491.120.970.931.561.632.191.991.81.731.491.481.351.13
3.838.985.998.6114.6122.198112.1153.9167.7194.3213.2351.6469.6715.1442.5399.6407.8434.1444.92380.43403.6
0.80002.82.4000000.32.52.81823.320.150.328.323.5718.0416.71
0.070.190.580.590.580.530.470.410.641.291.171.151.922.12.932.462.222.191.951.951.751.55
0.10.20.610.630.620.570.510.460.71.361.261.232.012.23.092.582.352.342.072.091.911.66
0.140.3311.041.061.050.80.791.061.761.741.82.652.953.923.773.53.633.563.83.543.54
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Prestige Consumer Healthcare provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Prestige Consumer Healthcare's financial health and stability.

Assets

Prestige Consumer Healthcare's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Prestige Consumer Healthcare must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Prestige Consumer Healthcare after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Prestige Consumer Healthcare's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0-14410263633-1863229376572789969339-35142164205-82
5559101011111110101313172325333129303232
012815910-201191325192846-5-269-4013189-60
-35-8-7-1011-147-331-512-1113-21-13-15-88-5-10-53
01412912342561010142423243880130249303632406
78742333736262417356962707985989892806154
0002211991511121011111548242730344640
31265153714566598667137111156176148210189217235259229
0000-23000000-10-2-6-3-3-12-10-17-22-9-7
-4-2-167-425-54-310-47-275-66211-58-805-223-694-1155-16-22-256-11
-4-1-166-425-31-300-48-275-66121-55-799-219-69116500-246-3
0000000000000000000000
-7-14631693-35-52-32-54162633-157-4065658569-209-200-68-251-5-137
1301002450000000654641-47-55-97-42
5-141633763-35-52-32-60161600-152-4164352561-209-249-131-279-7-185
----37.00-----6.00-1.00-33.00-1.00-6.00-16.00-13.00-12.00-1.00-2.00-7.00-19.00-9.00-5.00
0000000000000000000000
5-41125-7295-275-312-7514-9-567-62-531
3.611.85.550.630.771.444.566.258.78666.9127.3108.8150.2172.7145.7197.6178.8199.8213.4250.28221.93
0000000000000000000000

Prestige Consumer Healthcare stock margins

The Prestige Consumer Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Prestige Consumer Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Prestige Consumer Healthcare.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Prestige Consumer Healthcare's sales revenue. A higher gross margin percentage indicates that the Prestige Consumer Healthcare retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Prestige Consumer Healthcare's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Prestige Consumer Healthcare's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Prestige Consumer Healthcare's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Prestige Consumer Healthcare. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Prestige Consumer Healthcare's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Prestige Consumer Healthcare Margin History

Prestige Consumer Healthcare Gross marginPrestige Consumer Healthcare Profit marginPrestige Consumer Healthcare EBIT marginPrestige Consumer Healthcare Profit margin
2029e55.49 %31.45 %22.54 %
2028e55.49 %31.1 %21.24 %
2027e55.49 %30.59 %20.45 %
2026e55.49 %30.3 %20.25 %
2025e55.49 %30.26 %19.37 %
202455.49 %30.43 %18.6 %
202355.45 %31.29 %-7.3 %
202257.11 %30.36 %18.9 %
202158.03 %31.52 %17.46 %
202058.3 %31.19 %14.78 %
201956.96 %30.84 %-3.67 %
201855.72 %30.91 %32.62 %
201756.72 %30.99 %7.87 %
201657.95 %32.58 %12.39 %
201556.84 %29.29 %10.96 %
201456.18 %31.57 %12.15 %
201355.68 %30.76 %10.5 %
201251.55 %23.31 %8.43 %
201150.79 %22.62 %8.68 %
201052.43 %26.79 %10.97 %
200952.8 %26.27 %-63.47 %
200852.38 %28.38 %11.06 %
200752.74 %29.97 %12.2 %
200652.98 %31.41 %8.86 %
200551.92 %31.27 %-5.26 %

Prestige Consumer Healthcare Stock Sales Revenue, EBIT, Earnings per Share

The Prestige Consumer Healthcare earnings per share therefore indicates how much revenue Prestige Consumer Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Prestige Consumer Healthcare earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Prestige Consumer Healthcare's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Prestige Consumer Healthcare’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Prestige Consumer Healthcare's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Prestige Consumer Healthcare Revenue, EBIT and net profit per share

DatePrestige Consumer Healthcare Sales per SharePrestige Consumer Healthcare EBIT per sharePrestige Consumer Healthcare Earnings per Share
2029e25.14 undefined0 undefined5.67 undefined
2028e24.64 undefined0 undefined5.23 undefined
2027e24.25 undefined0 undefined4.96 undefined
2026e23.67 undefined0 undefined4.79 undefined
2025e23.06 undefined0 undefined4.47 undefined
202422.43 undefined6.82 undefined4.17 undefined
202322.6 undefined7.07 undefined-1.65 undefined
202221.38 undefined6.49 undefined4.04 undefined
202118.64 undefined5.88 undefined3.25 undefined
202018.85 undefined5.88 undefined2.78 undefined
201918.73 undefined5.78 undefined-0.69 undefined
201819.46 undefined6.01 undefined6.35 undefined
201716.52 undefined5.12 undefined1.3 undefined
201615.18 undefined4.95 undefined1.88 undefined
201513.56 undefined3.97 undefined1.49 undefined
201411.42 undefined3.61 undefined1.39 undefined
201312.13 undefined3.73 undefined1.27 undefined
20128.7 undefined2.03 undefined0.73 undefined
20116.69 undefined1.51 undefined0.58 undefined
20105.84 undefined1.56 undefined0.64 undefined
20095.9 undefined1.55 undefined-3.74 undefined
20086.13 undefined1.74 undefined0.68 undefined
20075.92 undefined1.77 undefined0.72 undefined
20065.93 undefined1.86 undefined0.53 undefined
200510.51 undefined3.29 undefined-0.55 undefined

Prestige Consumer Healthcare business model

Prestige Consumer Healthcare Inc. is a global health company that focuses on the development, manufacturing, and marketing of various OTC medications, dietary supplements, and cosmetics. The company is headquartered in Tarrytown, New York and was founded in 1996. Prestige Consumer Healthcare Inc. has become one of the leading companies in the over-the-counter market over the years and has gained worldwide recognition. The company's formation can be traced back to the acquisition of various brands by Irvington Ventures, which later merged into Prestige Brands International. The business model of Prestige Consumer Healthcare Inc. is designed to provide affordable and effective products. The company strives to offer its customers high-quality products that are capable of effectively meeting their needs. Through continuous research and development, Prestige Consumer Healthcare Inc. is always able to respond to changes in the industry and the needs of its customers. Prestige Consumer Healthcare Inc. has various divisions specializing in providing products in different healthcare areas. These include pain management, cough and cold, gastrointestinal health, allergies and sinus, and skincare. Within each division, the company offers a wide range of products tailored to different customer needs. The product range of Prestige Consumer Healthcare Inc. includes well-known brands such as BC Powder, Chloraseptic, Clear Eyes, Dramamine, Little Remedies, DenTek, Nix, and Comet. Each of these brands has proven to be reliable and effective in treating various health issues. In addition, the company also produces dietary supplements such as the well-known US brand Osteo Bi-Flex, which treats joint problems, and Forté Elements, specifically developed for athletes and sports enthusiasts, as well as a wide range of skincare products such as CeraVe and LaRoche-Posay. In recent years, Prestige Consumer Healthcare Inc. has also established a strong presence in the international market. The company operates sales offices in various countries and exports its products worldwide. By working with various distribution channels, the company manages to reach customers in different regions. In 2018, the company also expanded into the e-commerce industry. Prestige Consumer Healthcare Inc. acquired the e-commerce startup Clique Brands, which specializes in selling beauty and lifestyle products, to further drive growth in the e-commerce market. In summary, Prestige Consumer Healthcare Inc. is a company that focuses on providing high-quality and affordable health and beauty products. The company has a wide range of products in various divisions tailored to the different needs of its customers. Through continuous research and development and expansion into different markets, the company has achieved significant growth in recent years and established itself as one of the leading brands in the global OTC industry. Prestige Consumer Healthcare is one of the most popular companies on Eulerpool.com.

Prestige Consumer Healthcare Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Prestige Consumer Healthcare Revenue by Segment

Segmente2024202320222021202020192015
Net sales1.13 B USD1.13 B USD1.09 B USD943.32 M USD962.94 M USD--
Other revenues311,000 USD107,000 USD42,000 USD41,000 USD74,000 USD--
Net sales-----975.69 M USD-
Women's Health-----244.93 M USD-
Analgesics-----113.56 M USD-
Dermatologicals-----97.97 M USD-
Oral Care-----92.96 M USD-
Cough & Cold-----19.96 M USD-
Household Cleaning-----19.81 M USD-
Other OTC-----5.48 M USD-
Other revenues-----85,000 USD-
Eye & Ear Care-------
Gastrointestinal-------
Women's Health---268.1 M USD251.55 M USD--
Gastrointestinal---161.14 M USD172.91 M USD--
Analgesics---119.14 M USD114.01 M USD--
Eye & Ear Care---110.41 M USD112.16 M USD--
Dermatologicals---107.08 M USD103.01 M USD--
Oral Care---101.43 M USD93.21 M USD--
Cough & Cold---70.64 M USD111.11 M USD--
Other OTC---5.43 M USD5.07 M USD--
Household Cleaning-------
Women's Health240.42 M USD251.35 M USD264.51 M USD----
Gastrointestinal231.61 M USD226.58 M USD204.56 M USD----
Eye & Ear Care179.42 M USD171.08 M USD163.45 M USD----
Dermatologicals129.1 M USD123.74 M USD120.39 M USD----
Analgesics117.45 M USD119.26 M USD119.32 M USD----
Cough & Cold119.02 M USD126.99 M USD107.08 M USD----
Oral Care96.31 M USD97.63 M USD97.52 M USD----
Other OTC12.03 M USD11.1 M USD9.99 M USD----
North American OTC Healthcare958.26 M USD973.77 M USD967.88 M USD849.32 M USD859.37 M USD862.45 M USD566.26 M USD
International OTC Healthcare167.1 M USD153.95 M USD118.93 M USD94.05 M USD103.64 M USD93.52 M USD61.12 M USD
Household Cleaning-----19.81 M USD86.09 M USD

Prestige Consumer Healthcare Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Prestige Consumer Healthcare Revenue by Segment

DateRest of worldUnited States
2024238.89 M USD886.47 M USD
2023174.5 M USD953.22 M USD
2022176.71 M USD910.11 M USD
2021144.33 M USD799.04 M USD
2020150.36 M USD812.65 M USD
2019138.73 M USD837.05 M USD

Prestige Consumer Healthcare SWOT Analysis

Strengths

Prestige Consumer Healthcare Inc has several strengths that contribute to its competitive advantage in the market. Firstly, the company has a diverse portfolio of consumer healthcare products, including over-the-counter medications, dietary supplements, and personal care items. This wide range of offerings helps to cater to a broad customer base and provides multiple revenue streams.

Secondly, Prestige Consumer Healthcare Inc has a strong brand presence, with well-established names like BC Powder, Efferdent, and Chloraseptic. These trusted brands enjoy high brand recognition and customer loyalty, giving the company a significant advantage over its competitors.

Weaknesses

Despite its strengths, Prestige Consumer Healthcare Inc also faces certain weaknesses that could impede its growth and profitability. Firstly, the company heavily relies on a few key products for a significant portion of its revenue. This overreliance on a limited number of products increases the risk of revenue fluctuations if any of these products face market challenges or regulatory issues.

Additionally, Prestige Consumer Healthcare Inc operates in a highly competitive industry with various well-established players. Competing against larger and more resourceful competitors could pose challenges for the company, especially in terms of market share and pricing power.

Opportunities

The consumer healthcare industry offers several opportunities for Prestige Consumer Healthcare Inc to further expand its business. Firstly, the growing focus on health and wellness presents an opportunity for the company to develop and market new products that cater to this trend. This could include innovative dietary supplements, organic personal care items, or specialized medications.

Moreover, Prestige Consumer Healthcare Inc can leverage its existing strong brand presence to enter new markets or expand its distribution channels. This could involve partnerships with retailers, e-commerce platforms, or exploring international markets.

Threats

Despite the existing opportunities, Prestige Consumer Healthcare Inc faces certain threats that could pose challenges to its success. Firstly, regulatory changes or scrutiny could impact the company's ability to manufacture or market certain products, resulting in potential restrictions or increased compliance costs.

Additionally, sudden shifts in consumer preferences or disruptive technologies could render some of Prestige Consumer Healthcare Inc's products less relevant or obsolete, requiring continuous adaptation and innovation to stay competitive.

Prestige Consumer Healthcare Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Prestige Consumer Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Prestige Consumer Healthcare shares outstanding

The number of shares was Prestige Consumer Healthcare in 2023 — This indicates how many shares 49.889 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Prestige Consumer Healthcare earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Prestige Consumer Healthcare's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Prestige Consumer Healthcare’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Prestige Consumer Healthcare's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Prestige Consumer Healthcare dividend history and estimates

In 2023, Prestige Consumer Healthcare paid a dividend amounting to 0 USD. Dividend means that Prestige Consumer Healthcare distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Prestige Consumer Healthcare provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Prestige Consumer Healthcare’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Prestige Consumer Healthcare's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Prestige Consumer Healthcare Dividend History

DatePrestige Consumer Healthcare Dividend
20150.35 undefined

Prestige Consumer Healthcare dividend payout ratio

In 2023, Prestige Consumer Healthcare had a payout ratio of 23.15%. The payout ratio indicates the percentage of the company's profits that Prestige Consumer Healthcare distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Prestige Consumer Healthcare represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Prestige Consumer Healthcare could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Prestige Consumer Healthcare's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Prestige Consumer Healthcare Payout Ratio History

DatePrestige Consumer Healthcare Payout ratio
2029e23.15 %
2028e23.15 %
2027e23.15 %
2026e23.15 %
2025e23.15 %
202423.15 %
202323.15 %
202223.15 %
202123.15 %
202023.15 %
201923.15 %
201823.15 %
201723.15 %
201623.15 %
201523.15 %
201423.15 %
201323.15 %
201223.15 %
201123.15 %
201023.15 %
200923.15 %
200823.15 %
200723.15 %
200623.15 %
200523.15 %
Unfortunately, there are currently no price targets and forecasts available for Prestige Consumer Healthcare.

Prestige Consumer Healthcare latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.87 0.9  (3.56 %)2025 Q1
3/31/20241.15 0.98  (-14.94 %)2024 Q4
12/31/20231.05 1.06  (0.8 %)2024 Q3
9/30/20231.08 1.07  (-0.65 %)2024 Q2
6/30/20231.02 1.06  (3.95 %)2024 Q1
3/31/20231.05 -4.83  (-559.82 %)2023 Q4
12/31/20221.02 1.04  (1.61 %)2023 Q3
9/30/20221.01 1.02  (0.81 %)2023 Q2
6/30/20221.05 1.09  (3.95 %)2023 Q1
3/31/20220.9 0.91  (1.62 %)2022 Q4
1
2
3
4
5
...
8

Eulerpool ESG Scorecard© for the Prestige Consumer Healthcare stock

Eulerpool World ESG Rating (EESG©)

61/ 100

🌱 Environment

47

👫 Social

79

🏛️ Governance

58

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees50
Percentage of women in management—
Percentage of Asian employees6
Share of Asian management—
Percentage of Hispanic/Latino employees4
Hispano/Latino Management share—
Percentage of Black employees28
Black Management Share—
Percentage of white employees62
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Prestige Consumer Healthcare shareholders

%
Name
Stocks
Change
Date
6.92992 % Dimensional Fund Advisors, L.P.3,434,466-168,45512/31/2023
6.17962 % Macquarie Investment Management3,062,622-57,57612/31/2023
5.15694 % Ariel Investments, LLC2,555,77720,99112/31/2023
4.04053 % State Street Global Advisors (US)2,002,48590,59812/31/2023
2.32151 % Geode Capital Management, L.L.C.1,150,54053,76112/31/2023
2.26980 % Westwood Management Corp. (Texas)1,124,914-116,54712/31/2023
2.11330 % Allspring Global Investments, LLC1,047,3524,2783/31/2024
2.09452 % MFS Investment Management1,038,043-63,46112/31/2023
16.03839 % BlackRock Institutional Trust Company, N.A.7,948,624328,25212/31/2023
11.59395 % The Vanguard Group, Inc.5,745,96363,37512/31/2023
1
2
3
4
5
...
10

Prestige Consumer Healthcare Executives and Management Board

Mr. Ronald Lombardi59
Prestige Consumer Healthcare Chairman of the Board, President, Chief Executive Officer (since 2010)
Compensation 5.58 M
Ms. Christine Sacco48
Prestige Consumer Healthcare Chief Financial Officer
Compensation 1.96 M
Mr. Adel Mekhail61
Prestige Consumer Healthcare Executive Vice President - Marketing & Sales
Compensation 1.3 M
Mr. William P'Pool56
Prestige Consumer Healthcare Senior Vice President, General Counsel, Corporate Secretary
Compensation 1.29 M
Mr. Jeffrey Zerillo61
Prestige Consumer Healthcare Senior Vice President - Operations
Compensation 846,918
1
2

Prestige Consumer Healthcare Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Amazon.com Stock
Amazon.com
SupplierCustomer0,34-0,19-0,230,350,070,28
Walmart Stock
Walmart
SupplierCustomer0,240,07-0,26-0,47-0,100,29
ECMOHO Sp ADS-A Stock
ECMOHO Sp ADS-A
SupplierCustomer0,04-0,44-0,020,60-0,41-
BioGaia B Stock
BioGaia B
SupplierCustomer-0,17-0,47-0,63-0,46--0,01
1

Most common questions regarding Prestige Consumer Healthcare

What values and corporate philosophy does Prestige Consumer Healthcare represent?

Prestige Consumer Healthcare Inc represents a strong commitment to providing quality healthcare products to consumers. They strive to enhance the well-being of individuals through their diverse portfolio of trusted brands. Prestige Consumer Healthcare Inc values innovation, integrity, and customer satisfaction, ensuring that their products meet the highest standards of quality and efficacy. Their corporate philosophy focuses on continuous improvement, responsible business practices, and maintaining strong relationships with their partners. By prioritizing consumer health and wellness, Prestige Consumer Healthcare Inc has established itself as a reliable and leading player in the healthcare industry.

In which countries and regions is Prestige Consumer Healthcare primarily present?

Prestige Consumer Healthcare Inc is primarily present in the United States.

What significant milestones has the company Prestige Consumer Healthcare achieved?

Prestige Consumer Healthcare Inc has achieved several significant milestones. The company successfully expanded its portfolio by acquiring leading over-the-counter consumer healthcare brands. Prestige Consumer Healthcare Inc also achieved strong financial growth, consistently increasing its annual revenue. Additionally, the company established a strong market presence and expanded its distribution network. With a focus on innovation and customer satisfaction, Prestige Consumer Healthcare Inc has consistently introduced new and improved products to meet evolving consumer needs. These achievements have solidified the company's position as a prominent player in the healthcare industry.

What is the history and background of the company Prestige Consumer Healthcare?

Prestige Consumer Healthcare Inc is a renowned company with a rich history and strong background. Founded in 1996, it has grown to become a leading provider of healthcare products globally. Initially focused on over-the-counter pharmaceuticals, the company expanded its portfolio to include a wide range of personal care and household cleaning products. With a commitment to delivering quality and innovative solutions, Prestige Consumer Healthcare Inc has built a solid reputation among consumers and investors alike. Through strategic acquisitions and brand development, the company continues to thrive in the evolving healthcare industry. Prestige Consumer Healthcare Inc remains dedicated to enhancing the well-being of its customers and maintaining its position as a trusted household name.

Who are the main competitors of Prestige Consumer Healthcare in the market?

The main competitors of Prestige Consumer Healthcare Inc in the market include other leading companies in the healthcare industry such as Procter & Gamble, Johnson & Johnson, and Pfizer. These companies also specialize in providing consumer healthcare products and have a significant market presence. However, Prestige Consumer Healthcare Inc differentiates itself through its dedicated focus on delivering high-quality over-the-counter healthcare products that cater to specific consumer needs. With its strong brand identity and a wide range of trusted products, Prestige Consumer Healthcare Inc competes effectively in the market against these key industry players.

In which industries is Prestige Consumer Healthcare primarily active?

Prestige Consumer Healthcare Inc is primarily active in the healthcare industry.

What is the business model of Prestige Consumer Healthcare?

Prestige Consumer Healthcare Inc, a leading healthcare company, operates under a well-defined business model. The company focuses on acquiring, developing, and marketing a wide range of over-the-counter healthcare products. Prestige Consumer Healthcare Inc aims to enhance the lives of consumers by providing high-quality, innovative, and trusted solutions for their healthcare needs. With a diverse portfolio, the company offers various products spanning oral care, personal care, and over-the-counter medicines. By employing a strategic approach, Prestige Consumer Healthcare Inc continuously strives to deliver effective products that meet the evolving preferences and demands of consumers, ensuring their well-being and satisfaction.

What is the P/E ratio of Prestige Consumer Healthcare 2024?

The Prestige Consumer Healthcare P/E ratio is 17.28.

What is the P/S ratio of Prestige Consumer Healthcare 2024?

The Prestige Consumer Healthcare P/S ratio is 3.21.

What is the AlleAktien quality score of Prestige Consumer Healthcare?

The AlleAktien quality score for Prestige Consumer Healthcare is 5/10.

What is the revenue of Prestige Consumer Healthcare 2024?

The Prestige Consumer Healthcare revenue is 1.13 B USD.

How high is the profit of Prestige Consumer Healthcare 2024?

The Prestige Consumer Healthcare profit is 209.34 M USD.

What is the business model of Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc is a global company focused on health and personal care products. The company aims to produce and market high-quality products that improve people's well-being. Since its founding in 1996, Prestige Consumer Healthcare Inc has become one of the leading companies in this sector.

What is the Prestige Consumer Healthcare dividend?

Prestige Consumer Healthcare pays a dividend of 0 USD distributed over payouts per year.

How often does Prestige Consumer Healthcare pay dividends?

The dividend cannot currently be calculated for Prestige Consumer Healthcare or the company does not pay out a dividend.

What is the Prestige Consumer Healthcare ISIN?

The ISIN of Prestige Consumer Healthcare is US74112D1019.

What is the Prestige Consumer Healthcare WKN?

The WKN of Prestige Consumer Healthcare is A0DN17.

What is the Prestige Consumer Healthcare ticker?

The ticker of Prestige Consumer Healthcare is PBH.

How much dividend does Prestige Consumer Healthcare pay?

Over the past 12 months, Prestige Consumer Healthcare paid a dividend of 0.35 USD . This corresponds to a dividend yield of about 0.48 %. For the coming 12 months, Prestige Consumer Healthcare is expected to pay a dividend of 0 USD.

What is the dividend yield of Prestige Consumer Healthcare?

The current dividend yield of Prestige Consumer Healthcare is 0.48 %.

When does Prestige Consumer Healthcare pay dividends?

Prestige Consumer Healthcare pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Prestige Consumer Healthcare?

Prestige Consumer Healthcare paid dividends every year for the past 5 years.

What is the dividend of Prestige Consumer Healthcare?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Prestige Consumer Healthcare located?

Prestige Consumer Healthcare is assigned to the 'Health' sector.

Wann musste ich die Aktien von Prestige Consumer Healthcare kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Prestige Consumer Healthcare from 10/15/2015 amounting to 0.345 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2015.

When did Prestige Consumer Healthcare pay the last dividend?

The last dividend was paid out on 10/15/2015.

What was the dividend of Prestige Consumer Healthcare in the year 2023?

In the year 2023, Prestige Consumer Healthcare distributed 0 USD as dividends.

In which currency does Prestige Consumer Healthcare pay out the dividend?

The dividends of Prestige Consumer Healthcare are distributed in USD.

All fundamentals about Prestige Consumer Healthcare

Our stock analysis for Prestige Consumer Healthcare Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prestige Consumer Healthcare Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.